FDA Inspection
Ajanta Pharma Ltd.Ajanta Pharma Ltd. – FDA Inspection, Jun 28, 2019
Record Details
This FDA Inspection record concerns Ajanta Pharma Ltd., with an inspection on June 28, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · dcc8e789-9501-4bd0-9137-a7594d3fd15c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1097061
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Ajanta Pharma Ltd.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| April 21, 2026 | Not classified | Office of Inspections and Investigations | Drug Quality Assurance |
| March 5, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 7, 2017 | NAI | Center for Drug Evaluation and Research | Generic Drug Evaluation |
| March 20, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 6, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Ajanta Pharma Ltd.
- FDA Inspection 1313426 - 2026-04-21
- FDA Inspection 1235564 - 2024-03-05
- FDA Inspection 1009806 - 2017-02-07
- FDA Inspection 917795 - 2015-03-20
- FDA Inspection 801522 - 2012-09-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.